These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5732783)

  • 21. [The inherent contractility-reducing effect of various beta-adrenolytic agents on a heart-lung preparation in the dog].
    Schmidt HD; Schmier J
    Z Kreislaufforsch; 1967 Nov; 56(11):1137-50. PubMed ID: 5595876
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effects of beta-adrenergic blocking agents on the electrocardiogram of normal subjects].
    Bacuzzi E; Barbaresi F; Starcich R
    G Clin Med; 1966 Jul; 47(7):606-23. PubMed ID: 5981890
    [No Abstract]   [Full Text] [Related]  

  • 23. [Protective action in rats of propranolol injected jointly with aminophylline against electrocardiographic changes induced by pitressin].
    Setti L; Razzaboni G
    Boll Soc Ital Biol Sper; 1969 Oct; 45(19):1226-7. PubMed ID: 5396329
    [No Abstract]   [Full Text] [Related]  

  • 24. [Action of beta-adrenergic receptor blocking agents on the electrocardiogram of the rat].
    Villanti P; Mei V; Valora N; Fidanza A
    Boll Soc Ital Biol Sper; 1967 Dec; 43(23):1734-8. PubMed ID: 5589101
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade.
    Hood SG; Watson AM; May CN
    Peptides; 2005 Jul; 26(7):1248-56. PubMed ID: 15949643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative evaluation of the effectiveness of traditional antiarrhythmic beta-blocking drugs].
    Uggeri E; Guidi GC; Chilloni G
    Minerva Anestesiol; 1969 Apr; 35(4):429-36. PubMed ID: 5790003
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adrenergetic beta-receptor-blocking agents].
    Burckhardt D; Meier M
    Praxis; 1969 Sep; 58(36):1121-3. PubMed ID: 5820385
    [No Abstract]   [Full Text] [Related]  

  • 28. The peripheral vascular effects of beta adrenergic blocking agents in man.
    Mahon WA
    Angiologica; 1966; 3(5):304-17. PubMed ID: 5957697
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of autonomic blocking agents on plasma [K].
    Vick RL; Todd EP
    Proc West Pharmacol Soc; 1969; 12():124-8. PubMed ID: 5812285
    [No Abstract]   [Full Text] [Related]  

  • 30. A further study of the antagonistic action between alpha and beta blocking agents.
    Yamamura HI; Horita A
    Proc West Pharmacol Soc; 1968; 11():73-4. PubMed ID: 5734491
    [No Abstract]   [Full Text] [Related]  

  • 31. [Influence of beta-receptor blocking agents on urinary sodium excretion in man].
    Rahn KH; Johnson CE; McNay JL
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):296-7. PubMed ID: 4242438
    [No Abstract]   [Full Text] [Related]  

  • 32. Tissue distribution in rats of 1-(4'-nitrophenyl)-2-isopropylaminoethanol hydrochloride (INPEA) a highly specific beta-adrenergic blocking agent.
    Almirante L; Murmann W; Rugarli P; Fazi L
    Farmaco Sci; 1966 Sep; 21(9):637-44. PubMed ID: 5971374
    [No Abstract]   [Full Text] [Related]  

  • 33. Local anaesthetic activity of propranolol, a new beta-adrenergic blocking agent.
    Jaju BP; Sinha JN; Srimal RC
    J Indian Med Prof; 1966 Mar; 12(12):5663. PubMed ID: 5907340
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electrophysiological studies on beta-receptor-blocking agents with the aid of the microelectrode method].
    Pillat B; Otsuka Y
    Wien Med Wochenschr; 1969 Jan; 119(3):56-8. PubMed ID: 5764556
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes of the electrocardiographic pattern caused by hyperventilation induced with a new drug with myocardial beta receptor blocking action].
    Vettori G; Magaraggia L; Cecconello D
    Folia Cardiol; 1967; 26(6):357-62. PubMed ID: 5631882
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of the early circulatory effects of triiodothyronine in rats by propranolol.
    Kapitola J; Vilimovská D
    Physiol Bohemoslov; 1981; 30(4):347-51. PubMed ID: 6458055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The specificity of action of penbutolol and propranolol and their optical isomers].
    Kaiser J
    Arzneimittelforschung; 1980; 30(3):427-32. PubMed ID: 6104494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.
    Ablad B; Brogård M; Ek L
    Acta Pharmacol Toxicol (Copenh); 1967; 25():9-40. PubMed ID: 6072577
    [No Abstract]   [Full Text] [Related]  

  • 40. Adrenergic receptor blocking agents modifying the radioprotective action of T. A. B.
    Byron JW; Fox M
    Br J Radiol; 1969 May; 42(497):400. PubMed ID: 5781231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.